Rockefeller Capital Management L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 98,004 shares of REGN stock, worth $68.8 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

98,004

Previous 99,100 1.11%

Holding current value

$68.8 Million

Previous $104 Million 1.09%

% of portfolio

0.28%

Previous 0.3%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $1.12 Million - $1.32 Million	-1,096 Reduced 1.11%	98,004 $103 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $4.95 Million - $6 Million	-5,601 Reduced 5.35%	99,100 $104 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $821,447 - $903,948	-910 Reduced 0.86%	104,701 $101 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $1.24 Million - $1.41 Million	1,600 Added 1.54%	105,611 $92.8 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $17.5 Million - $21.4 Million	25,319 Added 32.17%	104,011 $85.6 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $2.26 Million - $2.68 Million	3,233 Added 4.28%	78,692 $56.5 Million
Q1 2023 May 17, 2023	SELL	$680.49 - $826.97 $18,373 - $22,328	-27 Reduced 0.04%	75,459 $62 Million
Q4 2022 Mar 06, 2023	SELL	$705.89 - $766.39 $3.83 Million - $4.16 Million	-5,424 Reduced 6.7%	75,486 $54.5 Million
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $481,560 - $607,704	-839 Reduced 1.03%	80,910 $55.7 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $5.43 Million - $7.32 Million	-9,903 Reduced 10.81%	81,749 $48.3 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $3.27 Million - $3.84 Million	5,492 Added 6.37%	91,652 $64 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $638,045 - $787,718	-1,174 Reduced 1.34%	86,160 $54.4 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $58.8 Million - $69.7 Million	-102,416 Reduced 53.97%	87,334 $52.9 Million
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $29.5 Million - $34.9 Million	62,498 Added 49.11%	189,750 $106 Million
Q1 2021 May 11, 2021	BUY	$446.73 - $548.2 $8.32 Million - $10.2 Million	18,631 Added 17.15%	127,252 $60.2 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $1.93 Million - $2.46 Million	4,041 Added 3.86%	108,621 $52.5 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $14.8 Million - $17.9 Million	-27,219 Reduced 20.65%	104,580 $58.5 Million
Q2 2020 Aug 12, 2020	SELL	$493.32 - $643.92 $1.34 Million - $1.75 Million	-2,710 Reduced 2.01%	131,799 $82.2 Million
Q1 2020 May 12, 2020	SELL	$336.18 - $494.43 $6.95 Million - $10.2 Million	-20,682 Reduced 13.33%	134,509 $65.7 Million
Q4 2019 Feb 07, 2020	SELL	$274.13 - $376.51 $22.4 Million - $30.8 Million	-81,823 Reduced 34.52%	155,191 $58.3 Million
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $974,611 - $1.13 Million	-3,564 Reduced 1.48%	237,014 $65.7 Million
Q2 2019 Aug 09, 2019	BUY	$299.6 - $414.82 $29.8 Million - $41.3 Million	99,548 Added 70.59%	240,578 $75.3 Million
Q1 2019 May 10, 2019	SELL	$372.08 - $439.57 $554,771 - $655,398	-1,491 Reduced 1.05%	141,030 $57.9 Million
Q4 2018 Feb 12, 2019	SELL	$335.82 - $403.04 $10.8 Million - $13 Million	-32,249 Reduced 18.45%	142,521 $53.2 Million
Q3 2018 Nov 02, 2018	SELL	$351.14 - $408.51 $618,357 - $719,386	-1,761 Reduced 1.0%	174,770 $70.6 Million
Q2 2018 Jul 31, 2018	SELL	$284.6 - $344.99 $543,016 - $658,240	-1,908 Reduced 1.07%	176,531 $60.9 Million
Q1 2018 May 09, 2018	BUY	$315.82 - $393.78 $56.4 Million - $70.3 Million	178,439 New	178,439 $61.4 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Regeneron Pharmaceuticals, Inc. Transaction History